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Endarterectomy, the preferred method of
femoropopliteal revascularization in most centers in
the 1960s, has gradually been replaced by arterial
bypass surgery. The early and late patency rates of
femoropopliteal endarterectomy were found to be
inferior to that of comparable bypass grafts.
Unpredictable reocclusions after endarterectomy
without preceding symptoms and the current lack of
experience with the technique have contributed to
the unpopularity of endarterectomy.1,2 However,
reported favorable long-term patency results of semi-
closed superficial femoral artery (SFA) endarterecto-
my have renewed our interest in this “old” tech-
nique.3-6 Since the advent of endovascular stents and
ring strip cutters, a less invasive “SFA remote
endarterectomy” technique has been introduced.7
Failure after endarterectomy may be caused by
recurrent SFA stenoses, similar to graft stenoses.
The concept that early revision of failing restenosed
but patent grafts increases long-term patency results
may also be applied to revascularization techniques
such as endarterectomy.8-10 However, there are, as
yet, no published data available on the incidence and
natural history of recurrent stenoses after SFA
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Purpose: The incidence, time-of-onset, and anatomical distribution of recurrent stenoses
after remote endarterectomy in superficial femoral artery (SFA) occlusive disease were
studied.
Methods: Patients undergoing SFA remote endarterectomy procedures were examined
with duplex surveillance. Patients were examined at 6 weeks, 3, 6, 9, and 12 months,
and then annually. Recurrent stenosis was defined as a peak systolic velocity ratio of 2.5
or higher. Duplex results were also compared with clinical and hemodynamic changes.
Results: Restenoses were identified in 46 of 101 (46%) limbs treated after a mean inter-
val of 5.8 months (range, 1 to 18 months). These 46 limbs formed the base of this study.
The median follow-up period was 25 months. Thirty-eight (83%) of all restenoses were
detected within 1 year. The lesions were located within the entire SFA and were not
specifically related to the adductor canal or distal stented region only. Multiple stenoses
were found in 21 limbs. Only 10 (22%) restenoses were correlated with worsening of
clinical symptoms, change of ankle-brachial index, or both. Ten of 23 cases (43%) of
nonrevised restenoses progressed to occlusion. These 10 occlusions occurred in all
patients with restenosis that developed within the first year. Nonrevised late restenoses
(more than 1 year) were not associated with any reocclusion.
Conclusion: Recurrent stenoses after SFA remote endarterectomy were noticed in 46 of
101 (46%) limbs. Most restenoses (83%) developed within the first year. In the nonre-
vised group, time-of-onset restenosis (less than 1 year) was correlated with a higher risk
for occlusion (P = .02). The location of restenoses were found without any anatomical
site of preference along the entire endarterectomized SFA segment. (J Vasc Surg
1999;30:106-13.)
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(remote) endarterectomy. It would also be interest-
ing to know the effect of using a stent within the
SFA at the distal end point to prevent intima dissec-
tion. Is the stent location correlated with a higher
incidence of restenoses?11-13
To gain further insight in the development of
recurrent stenoses, we studied the incidence, time-
of-onset, and anatomical distribution of recurrent
stenoses after SFA remote endarterectomy with
color-flow duplex scanning.14-18
MATERIAL AND METHODS
Patient population. From March 1994 through
June 1996, 101 SFA remote endarterectomy proce-
dures were performed in 88 patients with long seg-
mental SFA occlusive disease. In our institution,
SFA remote endarterectomy is the treatment of
choice in those patients with supragenicular
femoropopliteal occlusive disease who need surgery.
Veins, if available, are spared for infragenicular
femorodistal reconstructions. During follow-up, all
101 SFA remote endarterectomy procedures
entered our duplex surveillance program. Until
November 1997, 488 color-flow duplex scans were
done as part of this program. In 46 (46%) limbs in
42 patients, significant recurrent stenoses within the
endarterectomized SFA or at the proximal or distal
end were detected by means of serial color-flow
duplex examination (Fig 1). 
These 42 patients formed the base of this study.
The mean age of the 27 men and 15 women was 65
years (range, 43 to 78 years). Risk factors for athero-
sclerosis included smoking in 26 patients (62%), dia-
betes in 10 patients (24%), hypercholesterolemia in
13 patients (42%), and hypertension in 31 patients
(74%). Associated symptomatic coronary disease was
present in 13 of the 42 patients (32%), and cere-
brovascular disease was present in 5 of 42 patients
(12%). These percentages were similar to the group
without restenoses. All patients were treated for
chronic lower-extremity ischemia categories 1 to 3 in
32 of the 46 limbs (70%), category 4 in 5 of the 46
limbs (11%), and category 5 in 9 of the 46 (19%)
limbs, according to the Rutherford classification
(Society of Vascular Surgery/International Society for
Cardiovascular Surgery–North American Chapter cri-
teria).19 Femoropopliteal lesions consisted of lengthy
occlusions (43 limbs; 93%) or multiple stenoses (3
limbs; 7%). In 18 of the 43 cases (42%), the SFA was
occluded throughout most of its length, whereas the
remaining 15 cases had SFA occlusions for less than
half their length. Mean length of the endarterec-
tomized segment was 32 cm (range, 17 to 45 cm).
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The length of the endarterectomized segment was
related to the location and extent of the occlusion.
This was also the same as in the group without recur-
rent stenoses. The mean ± SD ankle-brachial blood
pressure index (ABI) in the 46 restenosed limbs
increased from 0.55 ± 0.20 preoperatively to 1.01 ±
0.17 after the remote endarterectomy procedure (P =
.014). The procedures were performed with general
anesthesia in the operating room by a vascular sur-
geon in close collaboration with an interventional
radiologist. All patients were given oral anticoagulants
1 day before surgery, and the drugs were continued
for a minimum of 6 months. 
Technique of remote endarterectomy. The
technique of the SFA remote endarterectomy using
a ring strip cutter (Mollring Cutter; Aspect Medical,
Portola Valley, Calif) has been described previously.7
In brief, a small cutdown at the groin was made.
Standard techniques were used to commence a semi-
closed endarterectomy at the origin of the SFA. A
ring stripper (Aesculap Instruments, Burlingame,
Calif) was advanced over the intima core downward
into the SFA under fluoroscopic guidance, until the
ring passed the occluded segment at the distal SFA.
Then the ring stripper was removed, and a similar-
size ring strip cutter was passed down along the
same cleavage plane until the same level was reached.
The cutting rings were then activated, and the distal
intima core was transected and removed. To prevent
any further dissection at the distal end point after
restoring blood flow, a steerable hydrophilic angled
or straight guidewire, ranging from 0.020 to 0.035
in (Terumo, Tokyo, Japan, or Schneider, Zurich,
Switzerland), was inserted. A short balloon-expand-
able Palmaz stent (Johnson and Johnson Inter-
ventional Systems, Warren, NJ) was inserted over
the wire and deployed at the distal overpass to tack
down the distal intima edge. Additionally, angio-
scopy or intravascular ultrasonography may be per-
formed to confirm proper stent apposition, although
this was not done routinely in the present study.
Usually, the endarterectomy was extended into the
common femoral artery to ensure good inflow.
Loose intima flaps or debris were removed from the
endarterectomized segment with a Fogarty Graft
Thrombectomy catheter (Baxter Health, Irvine,
Calif). Completion angiography was performed
before the arteriotomy was closed with an adjunct
patch plasty.
Surveillance. Patients were examined with color-
flow duplex scanning (HP Sonos 2000; Hewlett
Packard, Imaging Systems Division, Andover, Mass)
within 1 to 6 weeks after SFA remote endarterectomy
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Fig 1. A, Angiography after remote endarterectomy at 6 months follow-up showing recurrent stenosis
at the proximal superficial femoral artery (arrows). B, Duplex scanning at the site of restenosis with ele-
vated peak systolic velocity. C, Duplex scanning with normal flow pattern distal from the restenosis.
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and then at 3, 6, and 9 months, again at 1 year, and
then yearly thereafter. The degree of recurrent
restenosis was classified according to previously vali-
dated criteria from our institution, as published by
Legemate et al.20 Local increase of peak systolic veloc-
ity (PSV) at the site of stenosis (PSV-max) was com-
pared with the peak systolic velocity of a nearby nor-
mal arterial segment (PSV-normal). A PSV ratio
(PSV-max/PSV-normal) higher than 2.5 was consid-
ered to be a 50% diameter reduction or more. Spectral
waveform analysis was also used as a means of identi-
fying recurrent stenoses. If multiple stenoses were
detected during a follow-up examination, the stenosis
with the highest PSV ratio or the stenosis with clini-
cal symptoms was considered the most important
stenosis. Elevated PSV ratios within 6 weeks after the
operation that returned to normal values thereafter
were not considered recurrent stenoses. Clinical and
hemodynamic-sustained improvements were evaluat-
ed by means of recurrent symptoms and ABI mea-
surements with standard Doppler techniques at every
follow-up visit.
Definitions, study end points, and statistical
methods. The primary end point was any restenosis
or reocclusion. Secondary end points were radiolog-
ical or surgical interventions before occlusion, limb
salvage, or death. Recurrent stenoses were analyzed
according to maximum PSV ratio, location, and
time-of-onset. Location of recurrent stenoses was
classified into proximal, mid, and distal SFA/stent
regions. Postoperative ABI reduction of 0.15 or
more was regarded as a significant pressure reduc-
tion and an indicator for recurrent stenoses.
Cumulative primary and primary assisted patency
rates were calculated with the life table method,
according to the suggested standards for reports
dealing with lower-extremity ischemia.19 Difference
of mean ABI pre- and post-procedure were com-
pared by means of the Student t test.
RESULTS
The median follow-up time for the entire group
was 23.7 months. The overall cumulative primary
and primary assisted patency rates of the group of
101 SFA remote endarterectomy procedures at 30
months were 55% and 76%, respectively. The cumu-
lative primary and primary assisted patency rates of
the 46 stenosed limbs in the present study were 36%
and 70%, respectively.
In 46 of 101 limbs (46%), one or more signifi-
cant restenoses with a PSV ratio higher than 2.5
were identified (Fig 2).
Multiple stenoses were found in 21 limbs (46%);
these were not associated with a higher risk of fail-
ure. Location and number of (a)symptomatic recur-
rent stenoses, according to the most important
stenosis detected, are shown in Table I. No relation
was found between the location of the stenoses and
the risk of reocclusion.
The mean interval from operation to the detec-
tion of restenosis (time-of-onset) was 5.8 months
(range, 1 to 18 months). Thirty-eight (83%) of all
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Fig 2. The fate of 101 superficial femoral artery remote endarterectomy procedures and the manage-
ment of 46 limbs with Duplex-verified recurrent stenoses.
restenoses were detected within the first year, result-
ing in a 38% incidence of recurrent stenoses in the
first postoperative year (Fig 3).
The pathology of most restenoses was myointimal
hyperplasia, as established during three surgical revi-
sions. In five patients, temporary elevated PSV ratios
were found within 6 weeks postoperatively, but the
ratios returned to normal values shortly thereafter.
These were initially not regarded as restenoses and
were not related to failure in any one of them.
However, during follow-up, the same five patients
eventually developed restenoses at different locations,
and only the latter data were used in this study.
Thirty-six (78%) restenoses were asymptomatic
and showed no or only marginal reduction in ABI
(ABI reduction less than 0.15). Only 10 (22%) of all
restenoses were correlated with worsening of clinical
symptoms, and 13 (28%) showed an ABI reduction
of more than 0.15 (Table II).
The fate of nonrevised restenoses. Twenty-
three restenosed limbs were treated conservatively;
of these, 10 (43%) progressed to occlusion after a
median interval of 9.7 months. All 10 reocclusions
had recurrent stenoses developing within the first
year. Twelve limbs remained patent, without wors-
ening of their functional/hemodynamic situation.
Two patients with a stable stenosis died after 23 and
25 months, because of metastasized prostate cancer
and myocardial infarction.
The mean time-of-onset was 9.0 months (range,
1.5 to 24 months). Restenosis within the first year
was correlated with a higher risk for occlusion (P =
.02). The median time from operation to develop-
ment of restenosis was 4.7 months for the occlusive
group and 12.2 months for the patent group. All
nonrevised restenoses that developed after 1 year
remained patent during this study. 
Revised stenoses. All 10 symptomatic re-
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Fig 3. Interval from surgery to the detection of restenoses after 101 superficial femoral artery remote
endarterectomy procedures.
Table I. Location and incidence of recurrent
stenoses after 101 superficial femoral artery remote
endarterectomy procedures
Site Number Percent
Common femoral 3 7
SFA proximal 1⁄3 13 28
SFA mid 1⁄3 14 30
SFA distal 1⁄3 or stent 13 28
Popliteal 3 7
Total 46 100
SFA, Superficial femoral artery.
Table II. Clinical signs and ankle-brachial mea-
surements of hemodynamically significant recurrent
stenoses detected with color-flow duplex scanning
after 101 superficial femoral artery remote
endarterectomy procedures 
Ankle-brachial index
Clinical Signs No decline Decline > 0.15 Total
No 27 9 36
Yes 6 4 10
Total 33 13 46
stenosed limbs underwent revision. Thirteen limbs
with recurrent stenoses were revised at the discretion
of the attending physician. The decision not to
revise a stenosis was influenced by a stable PSV ratio,
a normal ABI, unwillingness of the patient to under-
go a second procedure, and reluctance of the sur-
geon to subject an asymptomatic patient to opera-
tion or percutaneous transluminal angioplasty. The
mean time-of-onset of the restenoses was 6.7
months (range, 1.8 to 13.2 months). Univariate
analysis showed that two factors, namely recurrent
symptoms and time-of-onset, were significantly dif-
ferent between the revised and nonrevised group.
No other differences were found between these
groups among demographic data and lesion charac-
teristics. Further multivariate analyses are now in
progress to compare the treatment outcome of
recurrent stenoses.
DISCUSSION
The role of endarterectomy in the management
of supragenicular SFA occlusive disease is question-
able. In contrast with the United States, several
European vascular centers still perform SFA
endarterectomy.21 This study has given us more
information regarding recurrent stenoses after
endarterectomy of the superficial femoral artery,
which has never been described thus far. 
Review of 488 duplex scans during a period of
nearly 4 years as part of our duplex surveillance pro-
gram revealed a high (46%) prevalence of recurrent
stenoses. This percentage is almost twice as high as
the reported graft stenoses after peripheral bypass
graft surgery.9,10,22 If restenoses after endarterecto-
my eventually lead to reocclusion in every case, we
would have noted a much higher failure rate than we
did in the present study. Two factors, revision and
time-of-onset, may be held responsible for this.
Revision of recurrent stenoses may have improved
our results and led to a cumulative primary assisted
patency rate of 70% at 30 months. Time-of-onset
significantly influenced the fate of nonrevised
restenoses. The six nonrevised restenoses, which
developed after the first postoperative year, did not
result in reocclusion. Nevertheless, our cumulative
patency rates were no better than the acceptable
long-term patency results of semiclosed endarterec-
tomy of the SFA reported by several other authors,
despite revision of recurrent stenoses in 23 cases.3-6
Another interesting finding was the distribution of
recurrent stenoses along the treated SFA. In the lit-
erature, the site of preference for SFA atherosclerot-
ic stenoses or occlusions, and recurrent stenoses
after percutaneous transluminal angioplasty (PTA)
has been the adductor canal.23,24 Although Scholten
et al reported that 72% of 50 femoropopliteal occlu-
sions were related to the adductor hiatus level,
Wensing et al could not establish a direct relation
between the surrounding tissues and the early onset
of atherosclerotic lesions.25,26 He investigated if
there was a preferential location or pattern for ather-
osclerosis along the circumference or the length of
the femoral artery, but found no common predilec-
tion site in the radial and/or longitudinal distribu-
tion of atherosclerotic lesions. We noticed that there
was no specific site of preference within the
endarterectomized segment for the development of
restenoses. The number of restenoses at the location
of the stent or distal SFA (Hunter’s canal) was com-
parable with other SFA segments. This can be
explained by the different etiologies of atheroscle-
rotic stenoses and recurrent stenoses caused by
myointimal hyperplasia. Intimal hyperplasia, which
was found during the three surgical revisions, is
related to the injured intima and media of the vessel.
Because the entire SFA was endarterectomized, the
whole SFA was at risk of developing recurrent
stenoses. 
Initially, we were concerned that the use of stents
in SFA remote endarterectomy would have detri-
mental effects on the long-term patency results.
Vroegindeweij et al recently reported that stenting
in the SFA after PTA for stenotic lesions does not
improve clinical or hemodynamic results.27 They
reported a similar 37% recurrent stenoses rate at 6 to
7 months after PTA with or without stenting. Gray
et al concluded in their study that the use of stents
after suboptimal PTA in the SFA had a very poor
outcome.13 They noticed a high incidence of
restenosis/reocclusion, with a 22% primary patency
rate at 1 year. Our findings cannot support these
reports, because recurrent stenoses did not affect the
Palmaz stent region more frequently than the upper
and middle part of the SFA. We believe that the use
of stents to tack down the intima at the distal end
point after remote endarterectomy is different from
other indications, such as preventing recoil or treat-
ing suboptimal PTA. However, overdilatation and
subsequent injury to the vessel wall during stent
deployment should be avoided. Otherwise, acceler-
ated healing response may induce myointimal hyper-
plasia at the location of the stent.27,28
Regarding progression to occlusion and time-of-
onset, there was a remarkable similarity between
graft stenoses and recurrent stenoses after remote
endarterectomy.
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Progression of graft stenoses caused by intimal
hyperplasia is considered to be one of the main caus-
es of graft failure. Several studies have reported that
early lesions increase the risk of graft thrombosis.29-32
Thereafter, progression of atherosclerosis may lead
to graft failure, but this is fairly benign compared
with intimal hyperplasia.30 Our findings confirm
that early (less than 1 year) recurrent asymptomatic
lesions progressed to reocclusion frequently in the
nonrevised group, whereas late restenoses did not.
Unfortunately, there is currently no information
about the arteriographic appearance of these late
restenoses and their etiology. Because half of all
restenoses in our study underwent (nonrandom-
ized) revision, we were not able to define the natur-
al history of recurrent stenoses. 
Although elevated PSV ratios within 6 weeks after
surgery suggested five very early recurrent stenoses, all
returned to normal values spontaneously. It is possible
that these were residual stenosis. However, all SFA
remote endarterectomy procedures were completed
with intraoperative angiography to ensure technical
adequacy. Another plausible explanation may be that
the locations of these five lesions were around the site
of the patch plasty used to close the arteriotomy of the
common femoral and proximal SFA. These vessel cal-
iber changes could induce flow turbulence, which was
initially misinterpreted as recurrent stenoses. Based on
our experience, we now consider elevated PSV ratios
higher than 2.5 within 6 weeks in combination with
normal angiogram results during the initial operation
no reason for concern. In our series, the aforemen-
tioned five “very early lesions” (less than 6 weeks) did
not lead to any failure. Other mechanisms that may
have contributed to diameter reduction, such as arter-
ial wall shrinking or so-called remodeling, were not
investigated in this study.33
Only 10 (22%) restenosed limbs were associated
with worsening of clinical signs. In six symptomatic
restenosed limbs, the ABI was unchanged. Mea-
surement of ABI did not contribute to the early
detection of recurrent stenoses. These findings are
similar to those of other investigators, who studied
the value of duplex scanning compared with repeat-
ed clinical and hemodynamic evaluation.11,34-36
They concluded that clinical assessment and ABI
measurements have been shown to be relatively
insensitive, because many preocclusive lesions devel-
op in the absence of significant clinical signs or
hemodynamic changes.
Some of the most important questions still to be
answered are can we identify patients with recurrent
stenoses after remote endarterectomy amenable for
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revision and does revision indeed improve long-term
patency results and at what cost? Can we prevent
recurrent stenoses at all? These problems need to be
studied first, before we can establish the true merits
of remote endarterectomy for SFA occlusive disease. 
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